Body

Each year, health care practitioners at Brigham and Women's Hospital place over a million orders through the electronic health records (EHR) system. Even though studies indicate that practitioners place more than 99.9 percent of orders for the correct patients, researchers at the Brigham analyzed that remaining 0.1 percent to determine and address the root causes of wrong-patient order errors. In an effort to improve patient safety, the Brigham required headshots for participating patients to be displayed in their EHR as part of a quality improvement program in the Emergency Department.

ARLINGTON HEIGHTS, Ill (November 13, 2020) - During the COVID-19 pandemic, attention has been focused on how those with both allergies and asthma might be affected should they become ill. A new study being presented at this year's virtual American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting examines hospital data to determine if those with allergic conditions had more severe COVID-related disease than those without.

ARLINGTON HEIGHTS, Ill (November 13, 2020) - COVID-19 has, among other things, pushed patients of all ages into greater use of telemedicine to carry out regular doctor visits. A new study being presented at this year's virtual American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting reveals that "show rates" for children with asthma - how often parents brought their kids to an appointment rather than being a "no show" - increased with the use of telemedicine during four months of the pandemic.

ARLINGTON HEIGHTS, Ill (November 13, 2020) - While research shows Black and Hispanic children suffer disproportionately with asthma, other allergic diseases have also been found to be more prevalent in those groups. A presentation at this year's virtual American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting reveals the disparities that exist for Black and Hispanic children when it comes to Atopic Dermatitis (AD), commonly known as eczema.

Exercising more than once per week is associated with a lower risk of developing Alzheimer's disease in patients with mild cognitive impairment, research published in the open access journal Alzheimer's Research and Therapy suggests. Mild cognitive impairment is a condition that causes people to have more problems with memory and thinking than is normal for someone their age. People with mild cognitive impairment have a ten-fold higher risk of developing Alzheimer's disease than the general population.

Researchers at Helmholtz Zentrum München together with LMU University Eye Hospital Munich and the Technical University of Munich (TUM) created a novel deep learning method that makes automated screenings for eye diseases such as diabetic retinopathy more efficient. Reducing the amount of expensive annotated image data that is required for the training of the algorithm, the method is attractive for clinics.

In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.

Ongoing support for several years and focus on the individual. These are success factors that make physical activity on prescription a workable concept for patients, including those who, after six months, have not reached their desired physical activity level, a University of Gothenburg thesis shows.

The thesis concerned comprises studies of 444 patients in Sweden who were offered what is known as "physical activity on prescription" (PAP) in primary care. These patients attended 15 different health centers in Gothenburg.

A growing body of evidence points to the health risks of using e-cigarettes (or "vaping"). But because e-cigarettes are marketed as a less harmful alternative to traditional cigarettes, it has been difficult to tell whether the association between vaping and disease is just a matter of smokers switching to vaping when they start experiencing health issues.

The risk of serious adverse effects on the blood status and bone marrow of patients during chemotherapy can be predicted by a model developed at Linköping University, Sweden. This research may make it possible to use genetic analysis to identify patients with a high probability of side effects. The study has been published in npj Systems Biology and Applications.

It is often difficult during cancer treatment to achieve a balance between getting rid of as many tumour cells as possible, while at the same time not causing serious side effects.

Bristol scientists have demonstrated a new virtual reality [VR] technique which should help in developing drugs against the SARS-CoV-2 virus - and enable researchers to share models and collaborate in new ways. The innovative tool, created by University of Bristol researchers, and published in the Journal of Chemical Information and Modeling, will help scientists around the world identify anti-viral drug leads more rapidly.

PHILADELPHIA (November 12, 2020) - Type 1 diabetes (T1D) is the third most common pediatric chronic disease in the United States, and the risk of the disease has risen sharply in non-Hispanic Black (NHB) children in the last 20 years, data show. Ironically, the significant advances in T1D therapeutics over recent years, especially new technologies, may have exacerbated racial disparities in diabetes treatment and outcomes.

New research from the University of Cincinnati (UC) finds that women with kidney failure have low rates of contraceptive use. The study, published in the journal Kidney Medicine, finds an overall contraceptive use rate of 5.3% among women with kidney failure undergoing dialysis in the United States.

New Rochelle, NY, November 10, 2020--A significant number of women would consider using cannabis to treat gynecological conditions, primarily gynecological pain. Women with a history of cannabis use are reported in a study in Journal of Women's Health. Click here ( http://doi.org/10.1089/jwh.2020.8437) to read the article now.

SAN FRANCISCO - Nov. 12, 2020 - The COVID-19 Early Treatment Fund (CETF), today announced that JAMA, The Journal of the American Medical Association, published the results of a Washington University School of Medicine in St. Louis double-blind, randomized controlled clinical trial that investigated whether the antidepressant medication fluvoxamine, if taken within seven days of first symptoms of COVID-19, can reduce the risk for respiratory deterioration.